Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
IXICO secures £2.7m contract for imaging analysis in Huntington’s disease trial.
Nov 02, 2026
Contract Type
contract
LondonBiotechnologyHealth CareMedical
Description
IXICO has been awarded a £2.7m contract to provide imaging analysis for a late-stage Huntington’s disease drug trial. This global Phase 3 contract will generate revenue over the next six years, marking IXICO's second such contract for Huntington’s disease in a year.
Company Information
Company
Ixico PLC
Location
London, England, United Kingdom
About
Ixico PLC is a London-based medical analytics company focused on accelerating the growth and global commercial reach of neurology technology platforms, addressing unmet clinical needs in neurological diseases, and developing and scaling product offerings across areas of drug development.